This paper analyzes the difference between Acute Lymphoblastic Leukemia (ALL) in adults and children. Specifically, it discusses the biological differences in cancer subtypes seen between these two groups, how they affect the possible treatment options, and how these differences play a role in the disparity in prognostic outcomes. In addition, this paper also examines how the age differences play a role in risk management for Acute Lymphoblastic Leukemia.
Cookie Settings
eScholarship uses cookies to ensure you have the best experience on our website. You can manage which cookies you want us to use.
Our Privacy Statement includes more details on the cookies we use and how we protect your privacy.
